Adrien Picod

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Letter by Robert et al Regarding Article, "Arterial Versus Mixed Venous Lactate Levels in 1526 Cardiac Intensive Care Patients".

Letter by Robert et al Regarding Article, "Arterial Versus Mixed Venous Lactate Levels in 1526 Cardiac Intensive Care Patients".

Journal: Circulation. Heart failure
Published: June 10, 2026

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Journal: mAbs
Published: May 21, 2026

Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.

Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.

Journal: mAbs
Published: May 21, 2026

Current and future strategies aiming at reducing catecholamine exposure in septic shock.

Current and future strategies aiming at reducing catecholamine exposure in septic shock.

Journal: Critical care (London, England)
Published: April 13, 2026

Toward endotype-guided renin-angiotensin-aldosterone system modulation in septic shock.

Toward endotype-guided renin-angiotensin-aldosterone system modulation in septic shock.

Journal: Critical care (London, England)
Published: March 29, 2026

Septic Shock and RAAS Dysregulation: Corticosteroids Don't Tell the Whole Story.

Septic Shock and RAAS Dysregulation: Corticosteroids Don't Tell the Whole Story.

Journal: Annals of intensive care
Published: March 06, 2026

Microangiopathies thrombotiques

Microangiopathies thrombotiques

Journal: La Revue du praticien
Published: January 23, 2026

cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies.

cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies.

Journal: ESC heart failure
Published: November 25, 2025

Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies.

Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies.

Journal: ESC heart failure
Published: November 25, 2025

Modulation of the Renin-Angiotensin System in Critically Ill Patients: Addressing Seven Key Questions for the Intensivist.

Modulation of the Renin-Angiotensin System in Critically Ill Patients: Addressing Seven Key Questions for the Intensivist.

Journal: Anesthesiology
Published: October 20, 2025

Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial.

Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial.

Journal: Critical care (London, England)
Published: September 23, 2025

Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress.

Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress.

Journal: iScience
Published: September 16, 2025
Showing 1-12 of 50

Last Updated: 09/26/2026